217 related articles for article (PubMed ID: 3722413)
1. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
[TBL] [Abstract][Full Text] [Related]
2. Morphometry of breast cancer. I. Comparison of the primary tumours and the axillary lymph node metastases.
Van der Linden HC; Baak JP; Smeulders AW; Lindeman J; Meyer CJ
Pathol Res Pract; 1986 May; 181(2):236-42. PubMed ID: 3737478
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.
van der Linden JC; Baak JP; Lindeman J; Hermans J; Meyer CJ
J Clin Pathol; 1987 Mar; 40(3):302-6. PubMed ID: 3558864
[TBL] [Abstract][Full Text] [Related]
4. The value of morphometry to classic prognosticators in breast cancer.
Baak JP; Van Dop H; Kurver PH; Hermans J
Cancer; 1985 Jul; 56(2):374-82. PubMed ID: 4005802
[TBL] [Abstract][Full Text] [Related]
5. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
7. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
8. Prediction of prognosis in axillary lymph node positive breast cancer patients: a statistical study.
Maehle BO; Skjaerven R
Br J Surg; 1984 Jun; 71(6):459-62. PubMed ID: 6722486
[TBL] [Abstract][Full Text] [Related]
9. Mitotic indexes as prognostic predictors in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
J Cancer Res Clin Oncol; 1992; 118(1):75-81. PubMed ID: 1729263
[TBL] [Abstract][Full Text] [Related]
10. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptor concentration in primary breast cancer and axillary node metastases.
Hawkins RA; Black R; Steele RJ; Dixon JM; Forrest AP
Breast Cancer Res Treat; 1981; 1(3):245-51. PubMed ID: 7348574
[TBL] [Abstract][Full Text] [Related]
12. A simple index to predict prognosis independent of axillary node information in breast cancer.
Seshadri R; Horsfall DJ; McCaul K; Leong AS
Aust N Z J Surg; 1997 Nov; 67(11):765-70. PubMed ID: 9396991
[TBL] [Abstract][Full Text] [Related]
13. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
[TBL] [Abstract][Full Text] [Related]
14. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
[TBL] [Abstract][Full Text] [Related]
15. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
16. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen expression and peanut agglutinin binding in primary breast cancer and lymph node metastases; lack of correlation with clinical, histopathological, biochemical and morphometric features.
van der Linden JC; Baak JP; Lindeman J; Smeulders AW; Meyer CJ
Histopathology; 1985 Oct; 9(10):1051-9. PubMed ID: 4085979
[TBL] [Abstract][Full Text] [Related]
18. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
Falco M
Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of proliferative activity in lymph node metastases of patients with breast cancer.
van Diest PJ; Matze-Cok E; Baak JP
J Clin Pathol; 1991 May; 44(5):416-8. PubMed ID: 2045501
[TBL] [Abstract][Full Text] [Related]
20. Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour.
Colpaert C; Vermeulen P; Jeuris W; van Beest P; Goovaerts G; Weyler J; Van Dam P; Dirix L; Van Marck E
J Pathol; 2001 Apr; 193(4):442-9. PubMed ID: 11276002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
